查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726197

细胞和基因疗法第三方物流市场规模、份额、趋势分析报告：按类型、产品、温度范围、治疗领域、最终用途、地区、细分市场、预测，2025-2030 年

Cell And Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report By Type, By Product, By Temperature Range, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

细胞和基因治疗第三方物流市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球细胞和基因治疗第三方物流市场预计到2030年将达到200.4亿美元，2025年至2030年期间的复合年增长率为11.05%。

该市场的成长主要受到细胞和基因疗法日益增长的需求的推动，这需要精确的处理、严格的温度控制以及製造商、医院和治疗中心之间的无缝协调。 CGT 是针对特定患者的，这意味着必须在有限的时间内收集、运输、修改和重新註入单一患者的细胞。任何后勤上的失败都可能意味着失去昂贵的、可能挽救生命的治疗方法。 CGT的个人化特性推动了对先进低温运输物流的需求，超低温储存和运输成为标准要求。

此外，CGT 的临床试验和商业批准不断增加，要求物流供应商扩大其产能，确保增加的治疗剂量能够送达患者，且不会影响品质。这种转变迫使生物製药公司寻求专业的第三方物流合作伙伴，以应对 CGT 供应链的复杂性，优化物流效率，同时确保遵守严格的监管要求。此外，不断增加的监管支持也促进了市场成长。美国FDA、EMA等全球监管机构对CGT的运输和储存实施了严格的指导，以维持其功效和安全性。为了遵守法规，物流供应商必须实施良好分销规范 (GDP) 和良好生产规范 (GMP)，这两项规范涵盖了从包装到即时追踪的供应链管理的所有方面。不遵守规定可能会导致货物被拒收，从而造成经济损失并延误患者护理。

此外，市场参与企业不断增加的倡议，如伙伴关係和联盟、服务扩展、产品发布和增加研发线产品，都促进了市场成长。例如，2025 年 3 月，DHL 收购了生命科学温控物流专家 CryoPDP。此次收购旨在加强该公司处理先进医疗治疗的基础设施。 CryoPDP 在超低温储存和即时监控解决方案方面的专业知识与 DHL 为生物製药公司提供端到端解决方案的策略一致。

细胞和基因治疗第三方物流市场报告重点

  • 根据类型，临床领域占据市场主导地位，因为市场参与者增加了研发活动，细胞治疗和基因治疗的产品平臺也在增加。
  • 从产品来看，由于监管部门核准的增加和商业化的扩大，细胞疗法预计将在 2024 年占据市场主导地位。 CAR-T 细胞疗法在癌症治疗中的成功在这一增长中发挥了关键作用，其中诺华、吉利德科学和百时美施贵宝等公司处于领先地位。
  • 根据温度范围，由于对不需要超低温或低温的基因疗法、生技药品和再生医学产品的需求不断增加，常温储存在 2024 年占据了最大的市场占有率。
  • 从治疗领域来看，由于迅速采用先进疗法治疗各种癌症，尤其是血液肿瘤和固体癌，肿瘤学在 2024 年占据了市场主导地位。
  • 根据最终用途，由于生技药品和特殊药物高度依赖温控储存和运输，预计生物製药公司将在 2024 年占据最大的市场占有率。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 科技
  • 定价模式分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章细胞和基因治疗第三方物流市场：按类型估计和趋势分析

  • 细分仪表板
  • 细胞和基因治疗第三方物流市场：类型变化分析
  • 细胞及基因治疗第三方物流规模及趋势分析（按类型）（2018-2030）
  • 临床
  • 商业的

第五章细胞和基因治疗第三方物流市场：按产品分類的估计和趋势分析

  • 细分仪表板
  • 细胞和基因治疗第三方物流市场：产品差异分析
  • 细胞及基因治疗第三方物流规模及趋势分析（依产品）（2018-2030）
  • 细胞疗法
  • 基因治疗

第六章细胞和基因治疗第三方物流市场：按温度范围的估计和趋势分析

  • 细分仪表板
  • 细胞和基因治疗第三方物流市场：温度范围变化分析
  • 2018-2030年细胞与基因治疗第三方物流规模及趋势分析（依温度范围）
  • 常温保存
  • 冷藏保管
  • 超低温储存
  • 低温储存

第七章细胞和基因治疗第三方物流市场：按治疗领域估计和趋势分析

  • 细分仪表板
  • 细胞与基因治疗第三方物流市场：治疗领域差异分析
  • 细胞与基因治疗第三方物流规模及趋势分析（依治疗领域）（2018-2030）
  • 肿瘤学
  • 神经病学
  • 心血管疾病
  • 眼科
  • 感染疾病
  • 其他的

8. 细胞和基因治疗第三方物流市场：按最终用途的估计和趋势分析

  • 细分仪表板
  • 细胞和基因治疗第三方物流市场：最终用途差异分析
  • 细胞和基因治疗第三方物流规模和趋势分析（按最终用途）（2018-2030）
  • 生物製药公司
  • CDMO/CMO
  • 其他的

第九章区域业务分析

  • 区域仪表板
  • 2018-2030年市场规模、预测与趋势分析
  • 北美洲
    • 2018年至2030年北美细胞和基因治疗第三方物流市场估计和预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲细胞与基因治疗第三方物流市场预测
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太细胞与基因治疗第三方物流市场预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018年至2030年拉丁美洲细胞和基因治疗第三方物流市场估计和预测
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲细胞和基因治疗第三方物流市场估计和预测（2018 - 2030）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Cencora Corporation
    • Cardinal Health
    • McKesson Corporation
    • EVERSANA
    • Knipper Health
    • Arvato SE
    • DHL
    • FedEx
    • Kuehne+Nagel
    • United Parcel Service of America, Inc.
Product Code: GVR-4-68040-550-5

Cell & Gene Therapy Third-Party Logistics Market Growth & Trends:

The global cell and gene therapy third-party logistics market is expected to reach USD 20.04 billion by 2030, expanding at a CAGR of 11.05% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is mainly due to rising demand for cell and gene therapies, which require precise handling, strict temperature controls, and seamless coordination between manufacturers, hospitals, and treatment centers. CGTs are patient-specific, which signifies that a single patient's cells must be collected, transported, modified, and reinfused within tight timelines. Any failure in logistics can result in the loss of an expensive, potentially life-saving therapy. The personalized nature of CGTs has increased the need for advanced cold chain logistics, with cryogenic storage and ultra-low temperature transportation becoming standard requirements.

In addition, the growing pipeline of CGT clinical trials and commercial approvals encourages logistics providers to scale their capabilities, ensuring that the increasing volume of therapies reaches patients without compromising quality. This shift is compelling biopharmaceutical companies to seek specialized 3PL partners that can handle the complexities of CGT supply chains, ensuring compliance with strict regulatory requirements while optimizing distribution efficiency. Moreover, the growing regulatory support is also one of the factors contributing to market growth. The U.S. FDA, EMA, and other global regulatory bodies impose stringent guidelines on the transportation and storage of CGTs to maintain their potency and safety. Regulatory compliance requires logistics providers to implement Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP) standards, which govern every aspect of supply chain management, from packaging to real-time tracking. Failure to comply can result in rejected shipments, financial losses, and treatment delays for patients.

Furthermore, growing initiatives by the market players, such as partnerships and collaborations, service expansion, product launches, and increasing pipeline products, contribute to market growth. For instance, in March 2025, DHL acquired CryoPDP, a specialist in temperature-controlled logistics for life sciences. The acquisition aims to strengthen the infrastructure for handling advanced therapies. CryoPDP's expertise in ultra-cold storage and real-time monitoring solutions aligns with DHL's strategy, providing end-to-end solutions for biopharma companies.

Cell And Gene Therapy Third-Party Logistics Market Report Highlights:

  • Based on type, the clinical segment dominated the market due to the increasing number of research and development activities by the market players coupled with the growing number of cell and gene therapies product pipelines.
  • Based on the product, cell therapies dominated the market in 2024 due to increasing regulatory approvals and expanding commercialization efforts. The success of CAR-T cell therapies for cancer treatment played a crucial role in this growth, with companies like Novartis, Gilead Sciences, and Bristol Myers Squibb driving widespread adoption.
  • Based on temperature range, ambient storage held the largest market share in 2024due to the increasing demand for gene therapies, biologics, and regenerative medicine products that do not require ultra-low or cryogenic temperatures.
  • Based on the therapeutic area, the oncology segment dominated the market in 2024due to the rapid adoption of advanced therapies for treating various cancers, particularly hematologic and solid tumors.
  • Based on end use, biopharmaceutical companies held the largest market share in 2024due to their high reliance on temperature-controlled storage and transportation for biologics and specialty drugs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Information Analysis
    • 1.4.2. Market Formulation & Data Visualization
    • 1.4.3. Data Validation & Publishing
  • 1.5. Model Details
    • 1.5.1. Commodity Flow Analysis (Model 1)
    • 1.5.2. Top Down Market Estimation (Model 2)
    • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
    • 1.5.4. Multivariate Analysis (Model 4)
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Technology Landscape
  • 3.5. Pricing Model Analysis
  • 3.6. Industry Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Cell & Gene Therapy Third-Party Logistics Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Cell & Gene Therapy Third-Party Logistics Market; Type Movement Analysis
  • 4.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Clinical
    • 4.4.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Commercial
    • 4.5.1. Commercial market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cell & Gene Therapy Third-Party Logistics Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Cell & Gene Therapy Third-Party Logistics Market; Product Movement Analysis
  • 5.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Cell Therapies
    • 5.4.1. Cell therapies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Gene Therapies
    • 5.5.1. Gene therapies market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Cell & Gene Therapy Third-Party Logistics Market; Temperature Range Movement Analysis
  • 6.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Temperature Range, 2018 to 2030 (USD Million)
  • 6.4. Ambient Storage
    • 6.4.1. Ambient storage market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Refrigerated Storage
    • 6.5.1. Refrigerated storage market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Ultra-Low Temperature Storage
    • 6.6.1. Ultra-Low temperature storage market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Cryogenic Storage
    • 6.7.1. Cryogenic storage market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Cell & Gene Therapy Third-Party Logistics Market; Therapeutic Area Movement Analysis
  • 7.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Neurology
    • 7.5.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Cardiovascular Diseases
    • 7.6.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Ophthalmology
    • 7.7.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. Infectious Diseases
    • 7.8.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Cell & Gene Therapy Third-Party Logistics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Cell & Gene Therapy Third-Party Logistics Market; End Use Movement Analysis
  • 8.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Biopharmaceutical Companies
    • 8.4.1. Biopharmaceutical Companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. CDMOs/CMOs
    • 8.5.1. CDMOs/CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. U.S. cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Canada cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Mexico cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Germany cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.3. UK
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. UK cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. France cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Italy cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Spain cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Denmark cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Sweden cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key country dynamics
      • 9.4.9.2. Competitive scenario
      • 9.4.9.3. Regulatory framework
      • 9.4.9.4. Norway cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Japan cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. China cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. India cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. South Korea cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Australia cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.7. Thailand
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Competitive scenario
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Thailand cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Brazil cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Competitive scenario
      • 9.6.3.3. Regulatory framework
      • 9.6.3.4. Argentina cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. South Africa cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Saudi Arabia cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. UAE cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Competitive scenario
      • 9.7.5.3. Regulatory framework
      • 9.7.5.4. Kuwait cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Share/Assessment Analysis, 2024
  • 10.3. Company Profiles
    • 10.3.1. Cencora Corporation
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Service benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Cardinal Health
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Service benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. McKesson Corporation
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Service benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. EVERSANA
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Service benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Knipper Health
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Service benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Arvato SE
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Service benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. DHL
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Service benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. FedEx
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Service benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Kuehne+Nagel
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Service benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. United Parcel Service of America, Inc.
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Service benchmarking
      • 10.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 6 Global Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 7 Global Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global Cell & Gene Therapy Third-Party Logistics Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 North America Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 12 North America Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 13 North America Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 14 North America Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 18 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 19 U.S. Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Canada Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 Canada Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 23 Canada Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 24 Canada Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 28 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Mexico Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Europe Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Europe Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Europe Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 34 Europe Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 35 Europe Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 UK Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 UK Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 UK Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 39 UK Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 40 UK Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Germany Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 Germany Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Germany Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 44 Germany Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 45 Germany Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 France Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 France Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 France Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 49 France Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 50 France Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Italy Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 Italy Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 53 Italy Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 54 Italy Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 55 Italy Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Spain Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 Spain Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 Spain Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 59 Spain Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 60 Spain Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 64 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 65 Denmark Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 69 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 70 Sweden Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Norway Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Norway Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Norway Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 74 Norway Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 75 Norway Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Japan Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Japan Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Japan Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 85 Japan Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 Japan Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 China Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 China Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 China Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 90 China Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 91 China Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 India Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 India Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 India Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 95 India Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 96 India Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 Australia Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 98 Australia Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 99 Australia Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 100 Australia Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 101 Australia Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 102 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 103 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 104 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 105 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 South Korea Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 108 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 109 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 110 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 111 Thailand Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 116 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 117 Latin America Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 118 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 119 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 120 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 121 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 122 Brazil Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 124 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 125 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 126 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 127 Argentina Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 128 MEA Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 129 MEA Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 130 MEA Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 131 MEA Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 MEA Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 133 MEA Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 135 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 136 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 137 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 138 South Africa Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 145 UAE Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 146 UAE Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 147 UAE Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 148 UAE Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Cell & Gene Therapy Third-Party Logistics Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Cell & Gene Therapy Third-Party Logistics Market: Type Key Takeaways
  • Fig. 14 Global Cell & Gene Therapy Third-Party Logistics Market: Type Movement Analysis
  • Fig. 15 Global Cell & Gene Therapy Third-Party Logistics Market, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cell & Gene Therapy Third-Party Logistics Market, for Commercial, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell & Gene Therapy Third-Party Logistics Market: Product Key Takeaways
  • Fig. 18 Global Cell & Gene Therapy Third-Party Logistics Market: Product Movement Analysis
  • Fig. 19 Global Cell & Gene Therapy Third-Party Logistics Market, for Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell & Gene Therapy Third-Party Logistics Market, for Gene Therapies, 2018 - 2030 (USD Million)
  • Fig. 21 Global Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Key Takeaways
  • Fig. 22 Global Cell & Gene Therapy Third-Party Logistics Market, Temperature Range Movement Analysis
  • Fig. 23 Global Cell & Gene Therapy Third-Party Logistics Market, for Ambient Storage, 2018 - 2030 (USD Million)
  • Fig. 24 Global Cell & Gene Therapy Third-Party Logistics Market, for Refrigerated Storage, 2018 - 2030 (USD Million)
  • Fig. 25 Global Cell & Gene Therapy Third-Party Logistics Market, for Ultra-Low Temperature Storage, 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell & Gene Therapy Third-Party Logistics Market, for Cryogenic Storage, 2018 - 2030 (USD Million)
  • Fig. 27 Global Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Key Takeaways
  • Fig. 28 Global Cell & Gene Therapy Third-Party Logistics Market, Therapeutic Area Movement Analysis
  • Fig. 29 Global Cell & Gene Therapy Third-Party Logistics Market, Oncology, 2018 - 2030 (USD Million)
  • Fig. 30 Global Cell & Gene Therapy Third-Party Logistics Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 31 Global Cell & Gene Therapy Third-Party Logistics Market, for cardiovascular diseases, 2018 - 2030 (USD Million)
  • Fig. 32 Global Cell & Gene Therapy Third-Party Logistics Market, for Ophthalmology, 2018 - 2030 (USD Million)
  • Fig. 33 Global Cell & Gene Therapy Third-Party Logistics Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 34 Global Cell & Gene Therapy Third-Party Logistics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 35 Global Cell & Gene Therapy Third-Party Logistics Market: End Use Key Takeaways
  • Fig. 36 Global Cell & Gene Therapy Third-Party Logistics Market, End Use Movement Analysis
  • Fig. 37 Global Cell & Gene Therapy Third-Party Logistics Market, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 38 Global Cell & Gene Therapy Third-Party Logistics Market, for CDMOs/CMOs, 2018 - 2030 (USD Million)
  • Fig. 39 Global Cell & Gene Therapy Third-Party Logistics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 40 Regional Marketplace: Key Takeaways
  • Fig. 41 Regional Outlook, 2024 & 2030
  • Fig. 42 North America Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 48 UK Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 49 France Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Norway Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 57 China Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 58 India Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East and Africa Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 68 UAE Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)